EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lacticaseibacillus rhamnosus GG enhances gefitinib efficacy and reduces treatment-related toxicity via propionyl-L-carnitine regulation

Siyuan Shen, Xi Xie, Liting Lu, Wenyao Ma, Haiyang Tu, Jiachao Zhang

Cell Reports · 2026-10 · 45 (10) · 118068

DOI: 10.1016/j.celrep.2026.118068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-10. Verfasst von Siyuan Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Food Science and Engineering, Key Laboratory of Food Nutrition and Functional Food of Hainan Province, Hainan University, Haikou 570228, Ch…. Hauptthemen laut MEDLINE: Gefitinib, Carnitine, Lacticaseibacillus rhamnosus, Antineoplastic Agents. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GefitinibCarnitineLacticaseibacillus rhamnosusAntineoplastic AgentsProbioticsAnimalsMiceHumansApoptosisSignal TransductionCell Line, TumorCarcinoma, Non-Small-Cell Lung

Stichwörter der Autor:innen

CP: cancerCP: microbiologyLacticaseibacillus rhamnosus GGgefitinibgut microbiomenon-small cell lung cancerpropionyl-L-carnitine

Substanzen

GefitinibCarnitineAntineoplastic Agents

Autor:innen und Institutionen

  • School of Food Science and Engineering, Key Laboratory of Food Nutrition and Functional Food of Hainan Province, Hainan University, Haikou 570228, China; Collaborative Innovation Center of One Health, Hainan University,…
  • Key Laboratory of Tropical Biological Resources of Ministry of Education and Hainan Engineering Research Center for Drug Screening and Evaluation, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, Chi…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Shen, S., Xie, X., Lu, L., Ma, W., Tu, H., & Zhang, J. (2026). Lacticaseibacillus rhamnosus GG enhances gefitinib efficacy and reduces treatment-related toxicity via propionyl-L-carnitine regulation. Cell Reports, 45(10), 118068. https://doi.org/10.1016/j.celrep.2026.118068

Vancouver

Shen S, Xie X, Lu L, Ma W, Tu H, Zhang J. Lacticaseibacillus rhamnosus GG enhances gefitinib efficacy and reduces treatment-related toxicity via propionyl-L-carnitine regulation. Cell Reports. 2026;45(10):118068. doi:10.1016/j.celrep.2026.118068

BibTeX
@article{Shen2026,
  author = {Shen, Siyuan and Xie, Xi and Lu, Liting and Ma, Wenyao and Tu, Haiyang and Zhang, Jiachao},
  title = {Lacticaseibacillus rhamnosus GG enhances gefitinib efficacy and reduces treatment-related toxicity via propionyl-L-carnitine regulation},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {10},
  pages = {118068},
  doi = {10.1016/j.celrep.2026.118068}
}
Kostenlos starten →